Trowbridge Stephen A's Form 4 filing
Angiodynamics Inc (ANGO) · filed Jul 21, 2026
- Accession no.
- 0001140361-26-029188
- Filed
- Jul 21, 2026, 8:32 PM ET
- Trade date
- Jul 16-20, 2026
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Trowbridge Stephen ACIK 0001624250 | Officer (EVP and CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Common Stock | FTax withholdingDisposed | −7,840 | $14.14 | −$110,857.6 | 248,789 | Direct | |
| Jul 17, 2026 | Common Stock | FTax withholdingDisposed | −3,510 | $13.51 | −$47,420.1 | 245,279 | Direct | |
| Jul 20, 2026 | Common Stock | FTax withholdingDisposed | −717 | $13.71 | −$9,830.07 | 244,562 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.